InnateDB Protein
|
IDBP-235121.6
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
SLC7A7
|
Protein Name
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
|
Synonyms
|
LAT3; LPI; MOP-2; y+LAT-1; Y+LAT1;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000380666
|
InnateDB Gene
|
IDBG-2809 (SLC7A7)
|
Protein Structure
|
|
Function |
Involved in the sodium-independent uptake of dibasic amino acids and sodium-dependent uptake of some neutral amino acids. Requires coexpression with SLC3A2/4F2hc to mediate the uptake of arginine, leucine and glutamine. Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. Involved in the transport of L- arginine in monocytes. {ECO:0000269PubMed:14603368, ECO:0000269PubMed:15280038, ECO:0000269PubMed:17329401, ECO:0000269PubMed:9829974, ECO:0000269PubMed:9878049}.
|
Subcellular Localization |
Basolateral cell membrane {ECO:0000269PubMed:15756301}; Multi-pass membrane protein {ECO:0000269PubMed:15756301}.
|
Disease Associations |
Lysinuric protein intolerance (LPI) [MIM:222700]: A metabolic disorder characterized by increased renal excretion of cationic amino acid (CAA), reduced CAA absorption from intestine, and orotic aciduria. On a normal diet, LPI patients present poor feeding, vomiting, diarrhea, episodes of hyperammoniaemic coma and growth retardation. Hepatosplenomegaly, osteoporosis and a life- threatening pulmonary involvement (alveolar proteinosis) are also seen. Biochemically LPI is characterized by defective transport of dibasic amino acids at the basolateral membrane of epithelial cells in kidney and intestine. {ECO:0000269PubMed:10080182, ECO:0000269PubMed:10631139, ECO:0000269PubMed:10655553, ECO:0000269PubMed:12402335, ECO:0000269PubMed:15776427, ECO:0000269PubMed:17764084, ECO:0000269PubMed:9829974}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
Highest expression in kidney and peripheral blood leukocytes. Weaker expression is observed in lung, heart, placenta, spleen, testis and small intestine. Expressed in normal fibroblasts and those from LPI patients. Also expressed in HUVECs, monocytes, retinal pigment epithelial cells, and various carcinoma cell lines, with highest expression in a colon-carcinoma cell line. {ECO:0000269PubMed:10080183, ECO:0000269PubMed:11078698, ECO:0000269PubMed:11742806, ECO:0000269PubMed:15280038, ECO:0000269PubMed:17197568, ECO:0000269PubMed:17329401, ECO:0000269PubMed:9829974}.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
Experimentally validated |
Total |
2
[view]
|
Protein-Protein |
2
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
|
|
Molecular Function |
Accession |
GO Term |
GO:0015171
|
amino acid transmembrane transporter activity
|
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR002293
Amino acid/polyamine transporter I
IPR004841
Amino acid permease/ SLC12A domain
|
PFAM |
PF13520
PF00324
|
PRINTS |
|
PIRSF |
PIRSF006060
|
SMART |
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q9UM01
|
PhosphoSite |
PhosphoSite-Q9UM01
|
TrEMBL |
G3V5W2
|
UniProt Splice Variant |
|
Entrez Gene |
9056
|
UniGene |
Hs.513147
|
RefSeq |
|
HUGO |
HGNC:11065
|
OMIM |
603593
|
CCDS |
CCDS9574
|
HPRD |
04667
|
IMGT |
|
EMBL |
AB011263
AB020532
AB031537
AF092032
AJ130718
AK314351
AL135998
BC003062
BC010107
BX161519
BX248291
CH471078
Y18474
|
GenPept |
AAC83706
AAH03062
AAH10107
BAA87623
BAA95120
BAB11849
BAG36987
CAA10198
CAB40136
CAD61952
CAD62619
EAW66245
EAW66246
EAW66247
EAW66248
|
|
|